Total Visits

Views
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.12

Total Visits Per Month

June 2021July 2021August 2021September 2021October 2021November 2021December 2021
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.0007122

File Downloads

Views
Safety and Immunogenicity of ChAd63MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.pdf8

Top country views

Views
United States8
United Kingdom4

Top cities views

Views
Ashburn4
Cambridge3
San Francisco2